Zymeworks Inc

(NYSE:ZYME)

Latest On Zymeworks Inc (ZYME):

Date/Time Type Description Signal Details
2023-05-18 13:02 ESTNewsZymeworks COO to step downN/A
2023-05-09 06:05 ESTNewsZymeworks Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-09 06:05 ESTNewsZymeworks Inc. (ZYME) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 17:21 ESTNewsZymeworks Non-GAAP EPS of -$0.34 beats by $0.20, revenue of $35.58M beats by $16.06MN/A
2023-05-08 17:21 ESTNewsZymeworks GAAP EPS of -$0.37 beats by $0.12, revenue of $35.58M beats by $16.06MN/A
2023-05-08 04:16 ESTNewsZymeworks Q1 2023 Earnings PreviewN/A
2023-04-10 14:26 ESTNewsZymeworks: Exciting Short Squeeze Candidate With Large Cash HoldingsN/A
2023-03-21 12:15 ESTNewsZymeworks a buy at Wells Fargo on royalty streams, future milestonesN/A
2023-03-20 21:19 ESTNewsZymeworks and Daiichi Sankyo end bispecific antibody dealN/A
2023-03-08 18:10 ESTNewsZymeworks gains 11% on Q4 earnings beat; provides update on cancer drugN/A
2023-03-08 02:40 ESTNewsZymeworks GAAP EPS of $4.65 beats by $2.16, revenue of $402.49M beats by $188.16MN/A
2023-03-08 02:40 ESTNewsZymeworks Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-03-08 02:40 ESTNewsZymeworks Inc. (ZYME) Q4 2022 Earnings Call TranscriptN/A
2023-03-06 21:19 ESTNewsZymeworks Q4 2022 Earnings PreviewN/A
2023-02-23 08:04 ESTNewsZymeworks: Completion Of Jazz Deal Provides New LifeN/A
2023-02-17 09:32 ESTNewsZymeworks (ZYME) presents at SVB Securities Global Biopharma Conference - SlideshowN/A
2023-01-19 12:13 ESTNewsJazz Pharma, Zymeworks post 84% overall survival for GIT cancer candidateN/A
2023-01-14 15:41 ESTNewsStocks To Watch: Economic Reports, Earnings Blockbusters And Political Minefields Lie Ahead Next WeekN/A
2023-01-13 15:49 ESTNewsZymeworks nears one-year high after insider purchaseN/A
2023-01-12 04:12 ESTNewsZymeworks: Good Data, Lots Of Cash, Stagnant StockN/A
2023-01-09 09:34 ESTNewsRevisiting Zymeworks After A Big Licensing DealN/A
2023-01-05 01:54 ESTNewsZymeworks says cash runway will fund operations through 2026; CMO leaving biotechN/A
2022-12-05 16:58 ESTNewsZymeworks to transfer listing to NasdaqN/A
2022-11-08 21:40 ESTNewsZymeworks Non-GAAP EPS of -$0.66 beats by $0.31, revenue of $2.6M misses by $1.95MN/A
2022-11-08 21:40 ESTNewsZymeworks Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-08 21:40 ESTNewsZymeworks Inc. (ZYME) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 03:06 ESTNewsZymeworks Q3 2022 Earnings PreviewN/A
2022-10-27 01:05 ESTNewsJazz Pharmaceuticals' Deal With Zymeworks Offers Good Reward-Risk RatioN/A
2022-10-26 08:26 ESTNewsZymeworks: A Binary Event With BTC Data By End-2022 Which May Trigger MilestoneN/A
2022-10-21 15:12 ESTNewsZymeworks downgraded at SVB citing Jazz licensing deal and clinical updatesN/A
2022-10-19 16:53 ESTNewsZymeworks surges 14% on license deal with Jazz for cancer drug zanidatamabN/A
2022-10-04 23:29 ESTNewsZymeworks draws bullish view at Wells Fargo ahead of multiple catalystsN/A
2022-09-06 17:29 ESTNewsZymeworks plunges 20% after Phase 1 data for cancer candidateN/A
2022-08-07 13:53 ESTNewsZymeworks Inc. (ZYME) CEO Ken Galbraith on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 19:14 ESTNewsZymeworks Non-GAAP EPS of -$0.92 beats by $0.02, revenue of $5.44M misses by $0.02MN/A
2022-08-04 03:57 ESTNewsZymeworks Q2 2022 Earnings PreviewN/A
2022-07-26 23:01 ESTNewsZymeworks: A Roller Coaster YearN/A
2022-06-27 18:43 ESTNewsZymeworks appoints new science chiefN/A
2022-06-15 17:40 ESTNewsZymeworks (ZYME) Presents At Jefferies Healthcare Conference - SlideshowN/A
2022-06-11 10:36 ESTNewsZymeworks adopts shareholder rights plan after All Blue Falcons proposalN/A
2022-05-26 20:17 ESTNewsZymeworks jumps after bidder All Blue Falcons raises state, promising data ahead of ASCO conference (update)N/A
2022-05-22 00:43 ESTNewsZymeworks rejects $10.50/share proposal from All Blue FalconsN/A
2022-05-20 07:51 ESTNewsZymeworks soars as bidder All Blue adds oncology expert to its teamN/A
2022-05-17 20:15 ESTNewsZymeworks And The Blue Falcon ElucidationN/A
2022-05-05 13:56 ESTNewsZymeworks GAAP EPS of -$1.19 misses by $0.33N/A
2022-05-05 13:55 ESTNewsZymeworks Inc. (ZYME) CEO Kenneth Galbraith on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-03 23:01 ESTNewsZymeworks buyout bid backed by former AstraZeneca oncology headN/A
2022-05-03 23:01 ESTNewsZymeworks Q1 2022 Earnings PreviewN/A
2022-04-29 15:20 ESTNewsZymeworks $10.50/share bid likely to be rejected, white knight possible - analystN/A
2022-04-28 22:20 ESTNewsZymeworks jumps on $10.50/share takeover bid (update)N/A

About Zymeworks Inc (ZYME):

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, and breast cancer; and ZW49, a biparatopic anti- human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; and BeiGene, Ltd. It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was founded in 2003 and is headquartered in Vancouver, Canada.

ZYME Quotes by TradingView

See Advanced Chart

General

  • Name Zymeworks Inc
  • Symbol ZYME
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 352
  • Fiscal Year EndDecember
  • IPO Date2017-04-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.zymeworks.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 46.99
  • Price/Book (Most Recent Quarter) 4.09
  • Enterprise Value Revenue 32.31
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$4.40
  • Next Year EPS Estimate -$3.02
  • Next Quarter EPS Estimate -$1.22
  • Operating Margin -481%
  • Return on Assets -26%
  • Return on Equity -55%
  • Revenue 38.95 million
  • Earnings Per Share -$1.63
  • Revenue Per Share $0.77
  • Gross Profit -129583000
  • Quarterly Earnings Growth 735.4%
View More

Highlights

  • Market Capitalization 1.52 billion
  • EBITDA -51618000
  • PE Ratio -2.55
  • Analyst Target Price $56.63
  • Book Value Per Share $8.90
View More

Share Statistics

  • Shares Outstanding 46.14 million
  • Shares Float 39.92 million
  • % Held by Insiders 985%
  • % Held by Institutions 78.81%
  • Shares Short 1.81 million
  • Shares Short Prior Month 750971
  • Short Ratio 2.59
  • Short % of Float 4%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 1.05
  • 52 Week High $59.03
  • 52 Week Low $25.44
  • 50 Day Moving Average 37.6
  • 200 Day Moving Average 43.73
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Zymeworks Inc (ZYME) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Zymeworks Inc (ZYME) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A-$0.74-$1.2540.63%
2020-09-302020-11-03$N/A-$1.43-$0.99-45%
2020-06-302020-08-05$12.36 million-$0.77-$0.8711.83%
2020-03-312020-05-07$8.27 million-$0.64-$1.0438.67%
2019-12-312020-03-02$1.88 million-$1.66-$0.88-88.55%
2019-09-302019-11-05$7.86 million-$0.70-$0.745.81%
2019-06-302019-08-02$7.88 million-$0.86-$0.60-44.31%
2019-03-312019-05-02$11.93 million-$0.43-$0.5216.86%
2018-12-312019-03-06$28.93 million$0.29$0.53-45.55%
2018-09-302018-11-06$2.05 million-$0.59-$0.648.43%
2018-06-302018-08-01$22 million-$0.22-$0.3333.85%
2018-03-312018-05-01$40000-$0.83-$0.67-23.86%
2017-12-312018-03-14$50.07 million$1.28-$0.034591.23%
2017-09-302017-11-08$119000-$0.64-$0.57-12.06%
2017-06-302017-08-08$1.34 million-$0.38-$0.5430.46%
2017-03-312017-04-28$230000-$1.19-$0.60-99.13%

Zymeworks Inc (ZYME) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Zymeworks Inc (ZYME) Chart:

Zymeworks Inc (ZYME) News:

Below you will find a list of latest news for Zymeworks Inc (ZYME) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Zymeworks Inc (ZYME) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50CALL0 0742.4TRUE00
2024-05-1750CALL0 0357.81TRUE00
2024-05-177.51.6CALL0 1131.5TRUE00
2024-05-17100.15CALL0 5374.84FALSE00
2024-05-1712.50.25CALL0 30FALSE00
2024-05-17150.05CALL0 10FALSE00
2024-05-1717.50CALL0 00FALSE00
2024-05-17200CALL0 00FALSE00
2024-05-1722.50CALL0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750PUT0 00FALSE00
2024-05-177.50.2PUT0 593.46FALSE00
2024-05-17101.2PUT0 33186.84TRUE00
2024-05-1712.50PUT0 0201.68TRUE00
2024-05-17150PUT0 0336.52TRUE00
2024-05-1717.50PUT0 0353.33TRUE00
2024-05-17200PUT0 0376.84TRUE00
2024-05-1722.50PUT0 0267.9TRUE00
2024-06-212.50CALL0 0388.14TRUE00
2024-06-2150CALL0 0120.02TRUE00
2024-06-217.50CALL0 082.98TRUE00
2024-06-21100.5CALL0 6483.11FALSE00
2024-06-2112.50.15CALL0 100FALSE00
2024-06-21150CALL0 00FALSE00
2024-06-2117.50CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 00FALSE00
2024-06-217.50PUT0 060.69FALSE00
2024-06-21100PUT0 0150.88TRUE00
2024-06-2112.50PUT0 0179.61TRUE00
2024-06-21150PUT0 0201.92TRUE00
2024-06-2117.50PUT0 0234.5TRUE00
2024-07-192.58.2CALL0 8200.95TRUE00
2024-07-1956.6CALL0 1194.72TRUE00
2024-07-197.52.75CALL0 2773.63TRUE00
2024-07-19100.55CALL2 30372.49FALSE-0.25-0.31
2024-07-1912.50.25CALL4 26878.7FALSE0.250
2024-07-19150.15CALL0 1110FALSE00
2024-07-1917.50.2CALL0 340FALSE00
2024-07-19200.54CALL0 90FALSE00
2024-07-192.50PUT0 00FALSE00
2024-07-1950PUT0 00FALSE00
2024-07-197.50.65PUT0 3596.41FALSE00
2024-07-19102.25PUT10 25266.17TRUE2.250
2024-07-1912.53.2PUT0 174.39TRUE00
2024-07-19155PUT0 2163.99TRUE00
2024-07-1917.50PUT0 0194.49TRUE00
2024-07-19200PUT0 0211.17TRUE00
2024-10-182.50CALL0 0238.61TRUE00
2024-10-1850CALL0 0141.64TRUE00
2024-10-187.52.01CALL30 3274.93TRUE-0.49-0.2
2024-10-18101.6CALL0 3181.84FALSE00
2024-10-1812.52.1CALL0 4289.62FALSE00
2024-10-18152.45CALL0 1285.36FALSE00
2024-10-1817.50.61CALL0 2696.05FALSE00
2024-10-18201CALL0 4123.22FALSE00
2024-10-1822.50CALL0 00FALSE00
2024-10-182.50PUT0 00FALSE00
2024-10-1850PUT0 085.97FALSE00
2024-10-187.51.05PUT0 392.42FALSE00
2024-10-18102.65PUT24 6568.19TRUE0.150.06
2024-10-1812.50PUT0 072.81TRUE00
2024-10-18150PUT0 0101.38TRUE00
2024-10-1817.50PUT0 0138.47TRUE00
2024-10-18200PUT0 0153.23TRUE00
2024-10-1822.50PUT0 0158.97TRUE00

Latest ZYME Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST71$5.46
Jun 13, 2022 7:59 PM EST21$5.46
Jun 13, 2022 7:59 PM EST400$5.455
Jun 13, 2022 7:59 PM EST400$5.455
Jun 13, 2022 7:59 PM EST100$5.455

Zymeworks Inc (ZYME) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520184013/0001193125-20-184013-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000005947819000030/0000059478-19-000030-index.htm
2019-02-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000005947819000046/0000059478-19-000046-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000005947819000079/0000059478-19-000079-index.htm
2019-05-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000005947819000176/0000059478-19-000176-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000031506620001283/0000315066-20-001283-index.htm
2019-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319000963/0000899243-19-000963-index.htm
2019-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319000964/0000899243-19-000964-index.htm
2019-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319000966/0000899243-19-000966-index.htm
2019-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319000993/0000899243-19-000993-index.htm
2019-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319000995/0000899243-19-000995-index.htm
2019-03-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319009170/0000899243-19-009170-index.htm
2019-03-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319009320/0000899243-19-009320-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319012635/0000899243-19-012635-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319012636/0000899243-19-012636-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319012637/0000899243-19-012637-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319012638/0000899243-19-012638-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319012639/0000899243-19-012639-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319012640/0000899243-19-012640-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319012641/0000899243-19-012641-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319016303/0000899243-19-016303-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319016304/0000899243-19-016304-index.htm
2019-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319019435/0000899243-19-019435-index.htm
2019-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319019436/0000899243-19-019436-index.htm
2019-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319019437/0000899243-19-019437-index.htm
2019-10-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319025828/0000899243-19-025828-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319027047/0000899243-19-027047-index.htm
2019-12-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924319029160/0000899243-19-029160-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320000877/0000899243-20-000877-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320000878/0000899243-20-000878-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320000880/0000899243-20-000880-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320002248/0000899243-20-002248-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320008000/0000899243-20-008000-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320008001/0000899243-20-008001-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320008004/0000899243-20-008004-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320008005/0000899243-20-008005-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320008007/0000899243-20-008007-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320010456/0000899243-20-010456-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320010693/0000899243-20-010693-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320012773/0000899243-20-012773-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320012774/0000899243-20-012774-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320012775/0000899243-20-012775-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320012776/0000899243-20-012776-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320012777/0000899243-20-012777-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320012778/0000899243-20-012778-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320018546/0000899243-20-018546-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320018549/0000899243-20-018549-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000089924320030450/0000899243-20-030450-index.htm
2019-08-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000093041319002283/0000930413-19-002283-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000095012320006723/0000950123-20-006723-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000095014219000207/0000950142-19-000207-index.htm
2019-05-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000095014219001069/0000950142-19-001069-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000095014220000385/0000950142-20-000385-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000106299319000947/0001062993-19-000947-index.htm
2019-05-29SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000106299319002437/0001062993-19-002437-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000110465920013799/0001104659-20-013799-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000110465920021760/0001104659-20-021760-index.htm
2020-03-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1403752/000110465920038329/0001104659-20-038329-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000114420419007231/0001144204-19-007231-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000117266120000853/0001172661-20-000853-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000117266120000864/0001172661-20-000864-index.htm
2019-01-22S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1403752/000119312519014025/0001193125-19-014025-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1403752/000119312519065609/0001193125-19-065609-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519065730/0001193125-19-065730-index.htm
2019-03-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1403752/000119312519078301/0001193125-19-078301-index.htm
2019-04-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519106033/0001193125-19-106033-index.htm
2019-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519114571/0001193125-19-114571-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519129279/0001193125-19-129279-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1403752/000119312519135165/0001193125-19-135165-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519135177/0001193125-19-135177-index.htm
2019-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519136932/0001193125-19-136932-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519156697/0001193125-19-156697-index.htm
2019-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519158184/0001193125-19-158184-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519159541/0001193125-19-159541-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519160991/0001193125-19-160991-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519166142/0001193125-19-166142-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519172154/0001193125-19-172154-index.htm
2019-06-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1403752/000119312519175738/0001193125-19-175738-index.htm
2019-06-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1403752/000119312519177481/0001193125-19-177481-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519177515/0001193125-19-177515-index.htm
2019-07-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000119312519187869/0001193125-19-187869-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519194770/0001193125-19-194770-index.htm
2019-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1403752/000119312519212141/0001193125-19-212141-index.htm
2019-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519212143/0001193125-19-212143-index.htm
2019-08-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519232566/0001193125-19-232566-index.htm
2019-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519248204/0001193125-19-248204-index.htm
2019-09-208-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519250708/0001193125-19-250708-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519258816/0001193125-19-258816-index.htm
2019-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519268596/0001193125-19-268596-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519276192/0001193125-19-276192-index.htm
2019-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519283417/0001193125-19-283417-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1403752/000119312519284726/0001193125-19-284726-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519284732/0001193125-19-284732-index.htm
2019-11-05POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1403752/000119312519284745/0001193125-19-284745-index.htm
2019-11-05S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1403752/000119312519284783/0001193125-19-284783-index.htm
2019-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1403752/000119312519284825/0001193125-19-284825-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519286057/0001193125-19-286057-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519294661/0001193125-19-294661-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312519298517/0001193125-19-298517-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520003014/0001193125-20-003014-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520006089/0001193125-20-006089-index.htm
2020-01-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1403752/000119312520011153/0001193125-20-011153-index.htm
2020-01-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1403752/000119312520013367/0001193125-20-013367-index.htm
2020-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520013371/0001193125-20-013371-index.htm
2020-01-27424B8Prospectus filed pursuant to Rule 424(b)(8)https://www.sec.gov/Archives/edgar/data/1403752/000119312520014620/0001193125-20-014620-index.htm
2020-01-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520015391/0001193125-20-015391-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000119312520038538/0001193125-20-038538-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520046466/0001193125-20-046466-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1403752/000119312520058902/0001193125-20-058902-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520058930/0001193125-20-058930-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520073718/0001193125-20-073718-index.htm
2020-03-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1403752/000119312520082593/0001193125-20-082593-index.htm
2020-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520094661/0001193125-20-094661-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520137639/0001193125-20-137639-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520154249/0001193125-20-154249-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520184013/0001193125-20-184013-index.htm
2020-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520189706/0001193125-20-189706-index.htm
2020-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520189854/0001193125-20-189854-index.htm
2020-09-038-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000119312520239038/0001193125-20-239038-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm
2019-01-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000134100419000035/0001341004-19-000035-index.htm
2019-01-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1403752/000134100419000052/0001341004-19-000052-index.htm
2019-01-30DEL AMDelaying amendmenthttps://www.sec.gov/Archives/edgar/data/1403752/000134100419000055/0001341004-19-000055-index.htm
2019-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000134100419000057/0001341004-19-000057-index.htm
2019-02-15F-10POSPost-effective amendment to a F-10EF registrationhttps://www.sec.gov/Archives/edgar/data/1403752/000134100419000125/0001341004-19-000125-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000134100419000165/0001341004-19-000165-index.htm
2019-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000134100419000289/0001341004-19-000289-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000134100419000356/0001341004-19-000356-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000134100419000364/0001341004-19-000364-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000134100419000417/0001341004-19-000417-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1403752/000140375220000004/0001403752-20-000004-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000140375220000006/0001403752-20-000006-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1403752/000140375220000012/0001403752-20-000012-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000140375220000014/0001403752-20-000014-index.htm
2020-11-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1403752/000140375220000020/0001403752-20-000020-index.htm
2020-11-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1403752/000140375220000022/0001403752-20-000022-index.htm
2020-03-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000163859920000302/0001638599-20-000302-index.htm
2020-03-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000163859920000303/0001638599-20-000303-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000163859920000304/0001638599-20-000304-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1403752/000163859920000460/0001638599-20-000460-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1403752/000165495420001571/0001654954-20-001571-index.htm
2019-01-31EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1403752/999999999519000046/9999999995-19-000046-index.htm
2019-11-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1403752/999999999519002513/9999999995-19-002513-index.htm
2019-04-12CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1403752/999999999719002845/9999999997-19-002845-index.htm
2020-01-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1403752/999999999720000304/9999999997-20-000304-index.htm
2020-01-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1403752/999999999720000305/9999999997-20-000305-index.htm
2020-01-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1403752/999999999720000307/9999999997-20-000307-index.htm
2020-01-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1403752/999999999720000308/9999999997-20-000308-index.htm
2020-01-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1403752/999999999720000309/9999999997-20-000309-index.htm
2020-01-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1403752/999999999720000310/9999999997-20-000310-index.htm
2020-01-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1403752/999999999720000312/9999999997-20-000312-index.htm

Zymeworks Inc (ZYME) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zymeworks Inc (ZYME). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 985%
Institutional Ownership: 7881%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-06David Kai Yuen PoonOfficerSell800.0019.2015,360.000.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319012641/0000899243-19-012641-index.htm
2019-07-08Anthony J. PolverinoChief Scientific OfficerBuy1,120.0012.4913,988.801,120.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319019436/0000899243-19-019436-index.htm
2019-01-08Neil A KlompasChief Financial OfficerBuy414.0012.485,166.721,201.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319000993/0000899243-19-000993-index.htm
2019-05-06Neil A KlompasChief Financial OfficerSell6,704.0019.22128,854.901,201.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319012640/0000899243-19-012640-index.htm
2020-09-14DIANA HAUSMANChief Medical OfficerBuy10,000.0015.74157,400.0013,718.00https://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm
2020-09-14DIANA HAUSMANChief Medical OfficerBuy10,000.0017.15171,500.0023,718.00https://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm
2019-01-08DIANA HAUSMANChief Medical OfficerBuy499.0012.486,227.522,499.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319000995/0000899243-19-000995-index.htm
2020-04-13Ali TehraniChief Executive OfficerBuy1,000.003.853,853.50257,009.00https://www.sec.gov/Archives/edgar/data/1403752/000089924320010693/0000899243-20-010693-index.htm
2019-12-12Anthony J. PolverinoChief Scientific OfficerBuy27,500.0015.00412,500.0028,620.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319029160/0000899243-19-029160-index.htm
2019-01-31ELI & CO LILLY10% Share HolderSell250,000.0016.004,000,000.002,898,647.00https://www.sec.gov/Archives/edgar/data/1403752/000005947819000030/0000059478-19-000030-index.htm
2020-01-08Anthony J. PolverinoChief Scientific OfficerBuy371.0019.547,249.3428,991.00https://www.sec.gov/Archives/edgar/data/1403752/000089924320000880/0000899243-20-000880-index.htm
2020-07-02Anthony J. PolverinoChief Scientific OfficerBuy488.0030.6614,962.0829,479.00https://www.sec.gov/Archives/edgar/data/1403752/000089924320018549/0000899243-20-018549-index.htm
2019-07-08DIANA HAUSMANChief Medical OfficerBuy520.0012.496,494.803,019.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319019437/0000899243-19-019437-index.htm
2020-01-08DIANA HAUSMANChief Medical OfficerBuy332.0019.546,487.283,351.00https://www.sec.gov/Archives/edgar/data/1403752/000089924320000878/0000899243-20-000878-index.htm
2020-09-14DIANA HAUSMANChief Medical OfficerBuy10,000.009.8298,200.0033,718.00https://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm
2020-07-02DIANA HAUSMANChief Medical OfficerBuy367.0030.6611,252.223,718.00https://www.sec.gov/Archives/edgar/data/1403752/000095012320006723/0000950123-20-006723-index.htm
2020-09-14DIANA HAUSMANChief Medical OfficerSell40,000.0045.001,800,000.003,718.00https://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm
2020-09-14DIANA HAUSMANChief Medical OfficerBuy10,000.0011.84118,400.0043,718.00https://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm
2020-11-02Ali TehraniChief Executive OfficerSell3,500.0039.04136,623.9056,361.00https://www.sec.gov/Archives/edgar/data/1403752/000089924320030450/0000899243-20-030450-index.htm
2019-03-29Ali TehraniChief Executive OfficerSell3,000.0016.2448,720.0059,286.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319009320/0000899243-19-009320-index.htm
2020-04-03Ali TehraniChief Executive OfficerBuy495.0033.3916,528.2059,781.00https://www.sec.gov/Archives/edgar/data/1403752/000089924320010456/0000899243-20-010456-index.htm
2020-04-03Ali TehraniChief Executive OfficerBuy80.0033.392,671.1959,861.00https://www.sec.gov/Archives/edgar/data/1403752/000089924320010456/0000899243-20-010456-index.htm
2020-01-27Troy CoxDirectorBuy7,500.0046.50348,750.007,500.00https://www.sec.gov/Archives/edgar/data/1403752/000089924320002248/0000899243-20-002248-index.htm
2019-05-06Neil A KlompasChief Financial OfficerBuy6,704.002.6617,832.647,905.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319012640/0000899243-19-012640-index.htm
2019-05-06Neil A KlompasChief Financial OfficerSell1,604.0019.2530,877.967,977.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319012640/0000899243-19-012640-index.htm
2019-05-06David Kai Yuen PoonOfficerBuy800.003.532,824.00800.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319012641/0000899243-19-012641-index.htm
2019-07-08Neil A KlompasChief Financial OfficerBuy464.0012.495,795.368,441.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319019435/0000899243-19-019435-index.htm
2020-01-08Neil A KlompasChief Financial OfficerBuy394.0019.547,698.768,835.00https://www.sec.gov/Archives/edgar/data/1403752/000089924320000877/0000899243-20-000877-index.htm
2020-07-02Neil A KlompasChief Financial OfficerBuy277.0030.668,492.829,112.00https://www.sec.gov/Archives/edgar/data/1403752/000089924320018546/0000899243-20-018546-index.htm
2019-05-06Neil A KlompasChief Financial OfficerBuy8,380.003.5329,581.409,581.00https://www.sec.gov/Archives/edgar/data/1403752/000089924319012640/0000899243-19-012640-index.htm